In 2020, Gesynta raised SEK 190 million in one of the year’s largest private biotech investments in the Nordic region. Now the company is one step closer to a new drug for systemic sclerosis. The future promises several innovative treatments for a number of inflammatory diseases, including cardiovascular disease and cancer.
A wireless lung function meter and smartphone app is making life easier for many asthma sufferers. The idea was born in a clinic at Astrid Lindgren Children’s Hospital and now the popular solution is spreading throughout Sweden.
CartaNA’s technology has been described as Google Maps for finding how specific genes are expressed in the body. The technique is set to have a major impact on accelerating the development of new drugs.
Top research is based on teamwork, with success derived from continually querying results. Pär Nordlund likens the work of a research director to the job of forming a talented corporate team.
Many years’ research has led Mats Wahlgren to a possible first drug treatment for acute manifestations of sickle cell anemia - a genetic condition that affects millions of people.
Oncopeptides has a new drug candidate for the treatment of a form of cancer of the blood, multiple myeloma, under development. KI Innovations played a key role in getting the project underway.
Aerocrine developed the world’s first nitrogen monoxide test for asthma sufferers. Today, the product is used around the globe to monitor asthma symptoms and adjust medication accordingly.
In Sweden, there are currently some 21,000 volunteers ready to respond to help cardiac arrest victims. A smartphone alert system guides them directly to victims – often faster than ambulances. The service, the result of research carried out at the Centrum för Hjärtstoppsforskning, is now ready for export markets.
Professor Hans von Holst is in his element where different disciplines intersect – where medicine meets technology. This is where his ideas have helped create, amongst other breakthroughs, MIPS, a technology that improves the protective properties of everyday helmets. Since 2011, the company has delivered around nine million helmets worldwide.
Children who exercise their working memory also find it easier to concentrate. This was one of the key insights that Torkel Klingberg gained from developing a clinical training programme for children with ADHD. The next step is a research-based tool to increase knowledge of mathematics among the world’s children.